Sales of Coherent Lasers for Ophthalmology Therapeutics Pass 10,000 Unit Milestone
Matthias Schulze, Segment Marketing Director explains, "These impressive sales numbers are a testament to the successful implementation of our strategy of combining technical innovation and superior performance with strong symbiotic partnerships with key customers in the medical field. This approach results in an excellent match between the performance and reliability of our products and the unique needs of target applications. For example, our excimer lasers are the preferred light source for LASIK because they offer higher beam uniformity than competitive products, a critical parameter in this application. And, in photocoagulation, we now supply green lasers at the long-used 532 nm wavelength as well as our award winning Genesis lasers at 577 nm, developed specifically to match the wavelength needs of this application."
Schulze adds, "Vision has a large and direct impact on a patient's quality of life, which is why Coherent is proud to have supported ophthalmic applications for nearly our entire 46 year history. For example, a now rarely used ophthalmic procedure called laser trabeculoplasty was one of the very first commercial laser applications, and Coherent successfully supplied ion lasers for this use."
Coherent Shared Services B.V.
Founded in 1966, Coherent, Inc. is a Russell 2000 Index company and a world leader in providing laser-based solutions to the commercial and scientific research markets. Please direct any questions to Matthias Schulze, segment marketing director, at 49 3030100786. For more information about Coherent, including product and financial updates, visit our website at http://www.Coherent.com.